392 related articles for article (PubMed ID: 28855138)
1. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
Ono A; Azukizawa H; Ito S; Nakamura Y; Asada H; Quan YS; Kamiyama F; Katayama I; Hirobe S; Okada N
Int J Pharm; 2017 Oct; 532(1):374-383. PubMed ID: 28855138
[TBL] [Abstract][Full Text] [Related]
2. Development of Novel Faster-Dissolving Microneedle Patches for Transcutaneous Vaccine Delivery.
Ono A; Ito S; Sakagami S; Asada H; Saito M; Quan YS; Kamiyama F; Hirobe S; Okada N
Pharmaceutics; 2017 Aug; 9(3):. PubMed ID: 28771172
[TBL] [Abstract][Full Text] [Related]
3. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens.
Matsuo K; Yokota Y; Zhai Y; Quan YS; Kamiyama F; Mukai Y; Okada N; Nakagawa S
J Control Release; 2012 Jul; 161(1):10-7. PubMed ID: 22306332
[TBL] [Abstract][Full Text] [Related]
4. Transcutaneous immunization of Streptococcus suis bacterin using dissolving microneedles.
Hsueh KJ; Chen MC; Cheng LT; Lee JW; Chung WB; Chu CY
Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():78-87. PubMed ID: 28131383
[TBL] [Abstract][Full Text] [Related]
5. Performance and characteristics evaluation of a sodium hyaluronate-based microneedle patch for a transcutaneous drug delivery system.
Hiraishi Y; Nakagawa T; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
Int J Pharm; 2013 Jan; 441(1-2):570-9. PubMed ID: 23137695
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel therapeutic approach using a retinoic acid-loaded microneedle patch for seborrheic keratosis treatment and safety study in humans.
Hiraishi Y; Hirobe S; Iioka H; Quan YS; Kamiyama F; Asada H; Okada N; Nakagawa S
J Control Release; 2013 Oct; 171(2):93-103. PubMed ID: 23791975
[TBL] [Abstract][Full Text] [Related]
7. Long-term stability of influenza vaccine in a dissolving microneedle patch.
Mistilis MJ; Joyce JC; Esser ES; Skountzou I; Compans RW; Bommarius AS; Prausnitz MR
Drug Deliv Transl Res; 2017 Apr; 7(2):195-205. PubMed ID: 26926241
[TBL] [Abstract][Full Text] [Related]
8. Microneedle Patches as Drug and Vaccine Delivery Platform.
Li J; Zeng M; Shan H; Tong C
Curr Med Chem; 2017; 24(22):2413-2422. PubMed ID: 28552053
[TBL] [Abstract][Full Text] [Related]
9. Dissolving Microneedle Patches for Dermal Vaccination.
Leone M; Mönkäre J; Bouwstra JA; Kersten G
Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
[TBL] [Abstract][Full Text] [Related]
10. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens.
Kommareddy S; Baudner BC; Oh S; Kwon SY; Singh M; O'Hagan DT
J Pharm Sci; 2012 Mar; 101(3):1021-7. PubMed ID: 22190403
[TBL] [Abstract][Full Text] [Related]
11. Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.
Kim MC; Lee JW; Choi HJ; Lee YN; Hwang HS; Lee J; Kim C; Lee JS; Montemagno C; Prausnitz MR; Kang SM
J Control Release; 2015 Jul; 210():208-16. PubMed ID: 26003039
[TBL] [Abstract][Full Text] [Related]
12. Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device.
Hirobe S; Azukizawa H; Matsuo K; Zhai Y; Quan YS; Kamiyama F; Suzuki H; Katayama I; Okada N; Nakagawa S
Pharm Res; 2013 Oct; 30(10):2664-74. PubMed ID: 23775442
[TBL] [Abstract][Full Text] [Related]
13. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch.
Moon S; Wang Y; Edens C; Gentsch JR; Prausnitz MR; Jiang B
Vaccine; 2013 Jul; 31(34):3396-402. PubMed ID: 23174199
[TBL] [Abstract][Full Text] [Related]
14. Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods.
Vrdoljak A; Allen EA; Ferrara F; Temperton NJ; Crean AM; Moore AC
J Control Release; 2016 Mar; 225():192-204. PubMed ID: 26774221
[TBL] [Abstract][Full Text] [Related]
15. Smart vaccine delivery based on microneedle arrays decorated with ultra-pH-responsive copolymers for cancer immunotherapy.
Duong HTT; Yin Y; Thambi T; Nguyen TL; Giang Phan VH; Lee MS; Lee JE; Kim J; Jeong JH; Lee DS
Biomaterials; 2018 Dec; 185():13-24. PubMed ID: 30216806
[TBL] [Abstract][Full Text] [Related]
16. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.
Vassilieva EV; Kalluri H; McAllister D; Taherbhai MT; Esser ES; Pewin WP; Pulit-Penaloza JA; Prausnitz MR; Compans RW; Skountzou I
Drug Deliv Transl Res; 2015 Aug; 5(4):360-71. PubMed ID: 25895053
[TBL] [Abstract][Full Text] [Related]
17. Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch.
Hirobe S; Azukizawa H; Hanafusa T; Matsuo K; Quan YS; Kamiyama F; Katayama I; Okada N; Nakagawa S
Biomaterials; 2015 Jul; 57():50-8. PubMed ID: 25913250
[TBL] [Abstract][Full Text] [Related]
18. Parameter optimization toward optimal microneedle-based dermal vaccination.
van der Maaden K; Varypataki EM; Yu H; Romeijn S; Jiskoot W; Bouwstra J
Eur J Pharm Sci; 2014 Nov; 64():18-25. PubMed ID: 25151530
[TBL] [Abstract][Full Text] [Related]
19. Effective humoral immune response from a H1N1 DNA vaccine delivered to the skin by microneedles coated with PLGA-based cationic nanoparticles.
Seok H; Noh JY; Lee DY; Kim SJ; Song CS; Kim YC
J Control Release; 2017 Nov; 265():66-74. PubMed ID: 28434892
[TBL] [Abstract][Full Text] [Related]
20. Formulation Approach that Enables the Coating of a Stable Influenza Vaccine on a Transdermal Microneedle Patch.
Ameri M; Ao Y; Lewis H
AAPS PharmSciTech; 2021 Jun; 22(5):175. PubMed ID: 34114100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
